MLB SCOPE

Innovative startup established for the development, production, and marketing of a new cardiological device called Emergency Ventricular Support (EVS).

EVS Features

EVS allows, with a relatively simple application protocol, a rapid and extremely effective rescue of the person affected by a serious and sudden cardiac pathology.

Application of the EVS device is also possible outside the hospital environment.

EVS allows a drastic reduction of the risk of death.

IP Status

Italian patent no. 102018000006538

granted on 08 July 2020

US patent 11,951,296 B2

granted on 09 April 2024

BREVETTI+

Through the BREVETTI plus Tender, granted MLB INNOVATION SRL a Contribution Voucher of approximately €70,000. In October 2023 the test campaign was successfully concluded through which the “Proof of Concept” and the TRL4 were achieved for the primary catheter, the left one (Left Ventricule).